Torray Investment Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.8M Sell
776,455
-27,116
-3% -$722K 3.2% 9
2025
Q4
$20M Buy
803,571
+50,574
+7% +$1.28M 2.87% 13
2025
Q3
$19.2M Buy
752,997
+102,107
+16% +$2.52M 2.6% 13
2025
Q2
$15.8M Buy
650,890
+517,746
+389% +$12.1M 2.29% 16
2025
Q1
$3.37M Buy
+133,144
New +$3.48M 0.5% 59

Other funds holding PFE

Torray Investment Partners's PFE Position: Q1 2026 in Review

Torray Investment Partners reduced its Pfizer (PFE) stake by 3.4% in Q1 2026, selling an estimated $722K and leaving 776,455 shares worth $21.8M. The position accounts for 3.2% of the portfolio, ranked #9.

Torray Investment Partners first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Torray Investment Partners held 776,455 shares of Pfizer worth $21.8M as of Q1 2026.
  • Torray Investment Partners sold 27,116 Pfizer shares in Q1 2026, an estimated $722K.
  • Pfizer made up 3.2% of Torray Investment Partners's portfolio in Q1 2026, its #9 holding.
  • Torray Investment Partners first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Torray Investment Partners's 13F filing for Q1 2026, filed 1 May 2026.